Simpler.Grants.gov Just Created a New Way for Applicants to Miss Deadlines
Simpler.Grants.gov may reduce waiting time, but applicants delaying SAM.gov registration could still face devastating submission failures at deadline.
From identifying the perfect funding opportunities to showcasing measurable success, we partner with you at every stage, ensuring your vision is realized and your results speak for themselves.
450M+
Direct & Follow-on Non-Dilutive Funding for Organizations
175+
Found Non-Dilutive Funding for Organizations
200+
Proposals Prepared for Organizations
100+
Measured Funding Outcomes for Organizations
Non-dilutive funding is essential for minimizing risks, fostering innovation, and promoting sustainable growth. We empower clients to navigate the non-dilutive funding landscape by becoming a strategic partner in driving growth and innovation.
We support high-growth startups, small businesses, and organizations within the innovation ecosystem. Our expert team identifies the best opportunities, crafts compelling applications, and evaluates project outcomes to ensure every step supports your unique goals. Partner with us to leverage our expertise and transform your innovative ideas into impactful realities, fueling your future.
Seeking non-dilutive funding? Need assistance with grant writing? Need post-award evaluation or reporting assistance? We would love to talk to you and answer all of your questions. Schedule a consult call today.
We share our knowledge and expertise, the latest opportunities for you, information about our field, and news within the industry.
Simpler.Grants.gov may reduce waiting time, but applicants delaying SAM.gov registration could still face devastating submission failures at deadline.
SBIR is reauthorized. Heightened oversight makes independent evaluation a strategic advantage for applicants in upcoming funding cycles
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.
BAAs offer a faster, more flexible path to DoW funding, especially for early-stage innovations still evolving toward real-world application.